Algorithm for the prevention of ventricular tachycardia onset: the Prevent Study

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Recurrent ventricular tachycardia (VT) and sudden cardiac arrest pose significant risks.
• Implantable cardioverter-defibrillators (ICDs) are crucial for managing these life-threatening arrhythmias.
• Optimizing ICD algorithm function is essential for patient safety and therapeutic efficacy.

Purpose of the Study:

• To investigate the impact of a rate-smoothing algorithm on the incidence of ventricular tachycardia in ICD patients.
• To assess the effect of active versus inactive rate-smoothing on VT onset.
• To evaluate the quality of life in patients undergoing ICD therapy with different algorithm settings.

Main Methods:

• The Prevent Study is a randomized crossover trial involving 240 patients with dual-chamber ICDs.
• Participants receive a Ventak AV ICD and are randomized to active or inactive rate-smoothing algorithm for 3 months, then cross over.
• Quality of life is assessed via questionnaires throughout the minimum 6-month follow-up period.

Main Results:

• This section is to be filled once the study is completed and results are available.
• Data analysis will focus on VT onset rates between active and inactive algorithm groups.
• Quality of life scores will be compared across different phases of the study.

Conclusions:

• This section is to be filled upon study completion.
• Expected conclusions will relate to the efficacy of rate-smoothing algorithms in preventing VT.
• Findings may inform future ICD programming strategies to enhance patient care and reduce adverse events.